APGE | Apogee TherapeuticsNASDAQCommon stock golden cross and death cross projections, cross tests and history

$135.07
-$0.01 (-0.01%)

Apogee Therapeutics (APGE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.

APGE stopped trading under this ticker on 2 Sep 2026.

Timeframe summary

Daily as of 2 Sep 16:00 ET

Price
above both $135.07 vs 50 $134.13 / 200 $91.97
Projection
No cross projected
Test
No active test
Last cross
Golden cross 14 Oct 2025 ยท projected 17 bars out

Weekly

No weekly data

4-hour as of 2 Sep 16:00 ET

Price
above both $135.07 vs 50 $134.64 / 200 $110.33
Projection
No cross projected
Test
No active test
Last cross
No cross on record

Cross history

2
crosses on record since 2024
1 golden1 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
14 Oct 2025Golden moderatedaily17 bars outNot tested
27 Dec 2024Deathdaily6 bars out2 bar cross test

About APGE

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$154M
4-hour coverageYes, since Oct 2025
History on recordSince 2024

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.